These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 37995060)

  • 1. Survey of attitude to human genome modification in Nigeria.
    Jibrilla M; Raji H; Okeke MI
    J Community Genet; 2024 Feb; 15(1):1-11. PubMed ID: 37995060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial DNA modification by CRISPR/Cas system: Challenges and future direction.
    Prakash R; Kannan A
    Prog Mol Biol Transl Sci; 2021; 178():193-211. PubMed ID: 33685597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [CRISPR/Cas9 technology in disease research and therapy: a review].
    Shi M; Shen Z; Zhang N; Wang L; Yu C; Yang Z
    Sheng Wu Gong Cheng Xue Bao; 2021 Apr; 37(4):1205-1228. PubMed ID: 33973436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expanding the Toolbox and Targets for Gene Editing.
    Dan J; Memczak S; Izpisua Belmonte JC
    Trends Mol Med; 2021 Mar; 27(3):203-206. PubMed ID: 33487569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Application of clustered regularly interspaced short palindromic repeats- associated protein 9 gene editing technology for treatment of HBV infection].
    Wang YD; Liang QF; Li ZY; Zhao CY
    Zhonghua Gan Zang Bing Za Zhi; 2018 Nov; 26(11):860-864. PubMed ID: 30616324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies for Optimization of the Clustered Regularly Interspaced Short Palindromic Repeat-Based Genome Editing System for Enhanced Editing Specificity.
    Wang YM; Wang HZ; Jian YZ; Luo ZT; Shao HW; Zhang WF
    Hum Gene Ther; 2022 Apr; 33(7-8):358-370. PubMed ID: 34963339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The genome editing revolution: review.
    Khalil AM
    J Genet Eng Biotechnol; 2020 Oct; 18(1):68. PubMed ID: 33123803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene editing in dermatology: Harnessing CRISPR for the treatment of cutaneous disease.
    Baker C; Hayden MS
    F1000Res; 2020; 9():281. PubMed ID: 32528662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR/Cas9 gene-editing strategies in cardiovascular cells.
    Vermersch E; Jouve C; Hulot JS
    Cardiovasc Res; 2020 Apr; 116(5):894-907. PubMed ID: 31584620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in Plant Epigenome Editing Research and Its Application in Plants.
    Qi Q; Hu B; Jiang W; Wang Y; Yan J; Ma F; Guan Q; Xu J
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Advances in CRISPR-Cas-mediated genome editing system in plants].
    Wang C; Wang K
    Sheng Wu Gong Cheng Xue Bao; 2017 Oct; 33(10):1712-1722. PubMed ID: 29082719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome Editing and Pathological Cardiac Hypertrophy.
    Kato T
    Adv Exp Med Biol; 2023; 1396():87-101. PubMed ID: 36454461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome editing using CRISPR/Cas9 to treat hereditary hematological disorders.
    Chen Y; Wen R; Yang Z; Chen Z
    Gene Ther; 2022 May; 29(5):207-216. PubMed ID: 33750926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TEAD4 regulates trophectoderm differentiation upstream of CDX2 in a GATA3-independent manner in the human preimplantation embryo.
    Stamatiadis P; Cosemans G; Boel A; Menten B; De Sutter P; Stoop D; Chuva de Sousa Lopes SM; Lluis F; Coucke P; Heindryckx B
    Hum Reprod; 2022 Jul; 37(8):1760-1773. PubMed ID: 35700449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An exciting time for genome editing: an interview with David R. Liu.
    Zhao W; Zhao KT
    Natl Sci Rev; 2019 May; 6(3):452-454. PubMed ID: 34691894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Need for Better Understanding Is the Major Determinant for Public Perceptions of Human Gene Editing.
    McCaughey T; Budden DM; Sanfilippo PG; Gooden GEC; Fan L; Fenwick E; Rees G; MacGregor C; Si L; Chen C; Liang HH; Pébay A; Baldwin T; Hewitt AW
    Hum Gene Ther; 2019 Jan; 30(1):36-43. PubMed ID: 29926763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [CRISPR/Cas-based genome editing in Aspergillus niger].
    Zheng X; Zheng P; Sun J
    Sheng Wu Gong Cheng Xue Bao; 2021 Mar; 37(3):980-990. PubMed ID: 33783162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome editing for crop improvement: Challenges and opportunities.
    Abdallah NA; Prakash CS; McHughen AG
    GM Crops Food; 2015; 6(4):183-205. PubMed ID: 26930114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of the CRISPR/Cas system for genome editing in microalgae.
    Zhang YT; Jiang JY; Shi TQ; Sun XM; Zhao QY; Huang H; Ren LJ
    Appl Microbiol Biotechnol; 2019 Apr; 103(8):3239-3248. PubMed ID: 30877356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.